linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Quarterly Results  
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 379.18
NSE Code AUROPHARMA
Dividend Yield % 0.00
Market Cap 839606.83
P/E 39.40
EPS 36.69
Face Value 1  
Type quaters
(Rs. in Million)
Particulars (Rs in Million) Dec 2025Sep 2025Jun 2025Mar 2025
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 86459.00 82857.00 78681.40 83821.20
Total Expenditure 68725.60 66076.00 62651.10 65902.00
PBIDT (Excl OI) 17733.40 16781.00 16030.30 17919.20
Other Income 1876.40 1205.90 1053.00 1348.10
Operating Profit 19609.80 17986.90 17083.30 19267.30
Interest 927.70 952.40 977.50 1150.20
Exceptional Items -653.30 0 0 0.00
PBDT 18028.80 17034.50 16105.80 18117.10
Depreciation 4647.30 4291.90 4057.00 4444.30
Profit Before Tax 13381.50 12742.60 12048.80 13672.80
Tax 4287.20 4277.90 3826.00 4322.60
Provisions and contingencies 0 0 0 0
Profit After Tax 9094.30 8464.70 8222.80 9350.20
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0 0 0 0
Net Profit 9094.30 8464.70 8222.80 9350.20
Minority Interest 4.90 3.20 5.50 6.40
Shares of Associates 3.7 16.6 19.2 -321.9
Other related items    
Misc. Expenses Written off 0 0 0 0
Consolidated Net Profit 9102.90 8484.50 8247.50 9034.70
Equity Capital 580.80 580.80 580.80 580.80
Face Value (IN RS) 1.00 1.00 1.00 1.00
Reserves 0 0 0 0
Calculated EPS 15.67 14.61 14.20 15.56
Calculated EPS (Annualised) 62.69 58.43 56.80 62.22
No of Public Share Holdings 279852902.00 279852902.00 279852902.00 279852902.00
% of Public Share Holdings 48.18 48.18 48.18 48.18
     
PBIDTM% (Excl OI) 20.51 20.25 20.37 21.38
PBIDTM% 22.68 21.71 21.71 22.99
PBDTM% 20.85 20.56 20.47 21.61
PBTM% 15.48 15.38 15.31 16.31
PATM% 10.52 10.22 10.45 11.15
 Notes Notes Notes Notes
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.